Telmisartan (Compound)

Synonyms:Telmisartan, 144701-48-4, Micardis, Pritor, Kinzalmono, BIBR 277, Semintra, 4'-((1,7'-Dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylic acid, BIBR-277, tolura, BIBR 277SE, Telmisartan [INN], Telmisartan Teva, Telmisartan Actavis, C33H30N4O2, BIBR-277-SE, 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid, BIBR-277SE, BIBR 277 SE, 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid, MFCD00918125, 4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid, CHEMBL1017, U5SYW473RQ, BIBR-277 SE, CHEBI:9434, 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid, DTXSID8023636, C09CA07, (1,1'-Biphenyl)-2-carboxylic acid, 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-, [1,1'-Biphenyl]-2-carboxylic acid, 4'-[(1,4'-dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-, NCGC00095150-01, Telmisattan, Targit, 1261396-33-1, 2-(4-{[4-methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl]methyl}phenyl)benzoic acid, 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propyl-benzimidazol-1-yl]methyl]phenyl]benzoic acid, 4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid, 4'[(1,4'-DIMETHYL-2'-PROPYL[2,6'-BI-1H-BENZIMIDAZOL]-1'-YL)METHYL][1,1'-BIPHENYL]-2-CARBOXYLIC ACID, DTXCID803636, Kinzal, Tazlok, Kinzal/Pritor, Micardis (TN), 4'-((1,7'-DIMETHYL-2'-PROPYL-1H,3'H-2,5'-BIBENZO[D]IMIDAZOL-3'-YL)METHYL)BIPHENYL-2-CARBOXYLIC ACID, SMR000466326, CAS-144701-48-4, Bay 68-9291, SR-01000759355, UNII-U5SYW473RQ, Telmisartana, Telmisartar, Telsite, Telday, HSDB 7590, 4'-[(1,4'-dimethyl-2'-propyl[2,6'-bi-1h-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid, 4'-[[4-METHYL-6-(1-METHYL-2-BENZIMIDAZOLYL)-2-PROPYL-1-BENZIMIDAZOLYL]METHYL]-2-BIPHENYLCARBOXYLIC ACID, Telmisartan [USAN:USP:INN:BAN], Telmisartan- Bio-X, YM-086, BAY68-9291, Telmisartan (Micardis), CPD000466326, TELMISARTAN [MI], Spectrum2_001976, Spectrum3_001089, Spectrum4_001261, Spectrum5_001053, TELMISARTAN [JAN], TELMISARTAN [HSDB], TELMISARTAN [USAN], TELMISARTAN [VANDF], SCHEMBL4464, TELMISARTAN [MART.], BSPBio_002738, GTPL592, KBioGR_001842, TELMISARTAN [USP-RS], TELMISARTAN [WHO-DD], MLS000759432, MLS001076687, MLS001424174, MLS006011851, BIDD:GT0365, SPECTRUM1505261, TELMISARTAN TEVA PHARMA, SPBio_002131, TELMISARTAN [EMA EPAR], Telmisartan (JP17/USP/INN), TELMISARTAN [GREEN BOOK], KBio3_001958, TELMISARTAN [EP IMPURITY], TELMISARTAN [ORANGE BOOK], Telmisartan for system suitability, HMS1922P07, HMS2051P16, HMS2090P17, HMS2093M22, HMS2231P07, HMS3393P16, HMS3655C08, HMS3715L17, HMS3750E19, Pharmakon1600-01505261, TELMISARTAN [EP MONOGRAPH], Telmisartan for peak identification, TELMISARTAN [USP MONOGRAPH], ALBB-028954, BCP04513, ONDUARP COMPONENT TELMISARTAN, TWYNSTA COMPONENT TELMISARTAN, Tox21_111452, BBL029085, BDBM50043280, CCG-39514, DL-511, HB2558, NSC759811, s1738, STK624049, TOLUCOMBI COMPONENT TELMISARTAN, AKOS005557501, KINZALKOMB COMPONENT TELMISARTAN, PRITORPLUS COMPONENT TELMISARTAN, Telmisartan, >=98% (HPLC), solid, Tox21_111452_1, AB07687, AC-2013, AM90292, CS-1699, DB00966, KS-1215, NC00296, NSC 759811, NSC-759811, TELMISARTAN COMPONENT OF ONDUARP, TELMISARTAN COMPONENT OF TWYNSTA, BAY-68-9291, MICARDIS HCT COMPONENT TELMISARTAN, MICARDISPLUS COMPONENT TELMISARTAN, NCGC00095150-02, NCGC00095150-03, NCGC00095150-04, NCGC00095150-06, NCGC00095150-07, NCGC00095150-08, TELMISARTAN [EMA EPAR VETERINARY], TELMISARTAN COMPONENT OF TOLUCOMBI, 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid, BT164444, HY-13955, SY052776, TELMISARTAN COMPONENT OF KINZALKOMB, TELMISARTAN COMPONENT OF PRITORPLUS, BCP0726000055, SBI-0206733.P001, TELMISARTAN COMPONENT OF MICARDIPLUS, TELMISARTAN COMPONENT OF MICARDISPLUS, FT-0631170, FT-0674836, SW197676-3, T-170, T2861, C07710, D00627, EN300-123532, AB00639941-06, AB00639941-07, AB00639941_08, AB00639941_09, A808270, L001035, Q733186, Q-101933, SR-01000759355-4, SR-01000759355-5, BRD-K73999723-001-02-2, Z1551967334, Telmisartan, European Pharmacopoeia (EP) Reference Standard, Telmisartan, United States Pharmacopeia (USP) Reference Standard, Telmisartan, Pharmaceutical Secondary Standard; Certified Reference Material, 4-(1,4-Dimethyl-2-propyl-2,6-bi-1H-benzimidazol-1-yl)methyl-1,1-biphenyl-2-carboxylicacid, Telmisartan for peak identification, European Pharmacopoeia (EP) Reference Standard, Telmisartan for system suitability, European Pharmacopoeia (EP) Reference Standard, 2-[4-[[4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl]methyl]phenyl]benzoic acid, 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid., 4''-((1,4''-dimethyl-2''-propyl(2,6''-bi-1H-benzimidazol)-1''-yl)methyl)-(1,1''-biphenyl)-2-carboxylic acid, 4''-((4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid, 4''-[(1,4''-dimethyl-2''propyl[2,6''-bi-1H-benzimidazol]-1''-yl)methyl]-[1,1''-biphenyl]-2-carboxylic acid, 4''-[(1,7''-dimethyl-2''-propyl-1H,3''H-2,5''-bibenzimidazol-3''-yl)methyl][1,1''-biphenyl]-2-carboxylic acid, 4''-[(1,7''-dimethyl-2''-propyl-1H,3''H-2,5''-bibenzimidazol-3''-yl)methyl]biphenyl-2-carboxylic acid, 4'-((1,7'-Dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylicacid, 4'-(1,7'-DIMETHYL-2'-PROPYL-1H-[2,5']BIBENZOIMIDAZOLYL-3'-YLMETHYL)-BIPHENYL-2-CARBOXYLIC ACID, 4'-[[2-n-Propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl]-methyl]-biphenyl-2-carboxylic acid, 4'-[[4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl]biphenyl-2-carboxylic Acid, 4'-[2-n-propyl-4-methyl-6-(1-methyl benzimidazol-2-yl)benzimidazol-1-yl methyl]biphenyl-2-carboxylic acid, 4'-{[4-methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl]methyl}-[1,1'-biphenyl]-2-carboxylic acid, TLS
Pubchem:PUBCHEM:65999
Id:be53cbc5-ce1c-5ca9-b5ce-26a0e70bb273
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Telmisartan's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Telmisartan.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Telmisartan.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.